Last updated on November 2017

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis


Brief description of study

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis

Detailed Study Description

The purpose of the study is to evaluate the effect of Velusetrag on: symptoms in subjects with gastroparesis, gastric emptying, and nausea improvement.

Clinical Study Identifier: TX5552

Contact Investigators or Research Sites near you

Start Over

MariCarmen Korngiebel-Rosique, MS, CRC

Gastroenterology Associates of Tidewater
Chesapeake, VA USA

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.